These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26240956)

  • 1. Pharmacodynamic interaction models in pediatric anesthesia.
    Hannam JA; Anderson BJ
    Paediatr Anaesth; 2015 Oct; 25(10):970-80. PubMed ID: 26240956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
    Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
    Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. My child is unique; the pharmacokinetics are universal.
    Anderson BJ
    Paediatr Anaesth; 2012 Jun; 22(6):530-8. PubMed ID: 22226125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and analysis of individualized pharmacokinetics and pharmacodynamics for volatile anesthesia.
    Krieger A; Panoskaltsis N; Mantalaris A; Georgiadis MC; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2014 Jan; 61(1):25-34. PubMed ID: 23899590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children.
    Anderson BJ; Hannam JA
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1393-408. PubMed ID: 26155821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of PK/PD modeling to intravenous anesthesia.
    Minto CF; Schnider TW
    Clin Pharmacol Ther; 2008 Jul; 84(1):27-38. PubMed ID: 18463625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.
    Admiraal R; van Kesteren C; Boelens JJ; Bredius RG; Tibboel D; Knibbe CA
    Arch Dis Child; 2014 Mar; 99(3):267-72. PubMed ID: 24356807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target controlled anaesthetic drug dosing.
    Schwilden H; Schüttler J
    Handb Exp Pharmacol; 2008; (182):425-50. PubMed ID: 18175103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic considerations of general anesthesia in pediatric subjects.
    Anderson BJ; Morse JD; Hannam JA; Cortinez LI
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):279-295. PubMed ID: 32148110
    [No Abstract]   [Full Text] [Related]  

  • 13. On the use of multivariable piecewise-linear models for predicting human response to anesthesia.
    Lin HH; Beck CL; Bloom MJ
    IEEE Trans Biomed Eng; 2004 Nov; 51(11):1876-87. PubMed ID: 15536890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc.
    Rosario MC; Jacqmin P; Dorr P; van der Ryst E; Hitchcock C
    Clin Pharmacol Ther; 2005 Nov; 78(5):508-19. PubMed ID: 16321617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?
    Barker CI; Standing JF; Turner MA; McElnay JC; Sharland M
    Curr Opin Infect Dis; 2012 Jun; 25(3):235-42. PubMed ID: 22517604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms and their development in children: implications for pharmacokinetics and pharmacodynamics in anesthesia.
    Potts AL; Cheeseman JF; Warman GR
    Paediatr Anaesth; 2011 Mar; 21(3):238-46. PubMed ID: 20561229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.
    Abdel-Rahman SM; Kauffman RE
    Annu Rev Pharmacol Toxicol; 2004; 44():111-36. PubMed ID: 14744241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.
    Martini C; Olofsen E; Yassen A; Aarts L; Dahan A
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):719-28. PubMed ID: 22111858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.